Johnson,Matthey PLC
17 July 2001
Chairman's Statement
At Johnson Matthey's AGM
Commenting on current trading at today's Annual General Meeting, Michael
Miles, Chairman of Johnson Matthey, said:
'Johnson Matthey has made a good start to the new financial year with
operating profit and earnings for the first quarter comfortably ahead of last
year.
Catalysts and Chemicals Division has produced most of the growth.
Autocatalyst sales have remained strong benefiting from the global spread of
emissions legislation and the introduction of our new process technology.
Demand for platinum group metal refining has also been good which has
benefited our Chemicals business.
On 9 July we announced we had acquired over 50% of the shares in Meconic plc
and that our offer for the company had gone unconditional. This acquisition
provides a European base for our Pharmaceutical Materials business. It will
provide opportunities to sell existing products into new markets and to
combine research and development, manufacturing and marketing resources.
The outlook for the group as a whole for the rest of the year remains
encouraging and we anticipate continued good growth.'
Enquiries:
Chris Clark, Chief Executive 020 7269 8435
John Sheldrick, Group Finance Director 020 7269 8438
Howard Lee, Gavin Anderson & Co 020 7496 1401
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.